| 84.268 |
FEDERAL DIRECT STUDENT LOANS |
$2.14M |
| 84.063 |
FEDERAL PELL GRANT PROGRAM |
$1.21M |
| 21.027 |
CORONAVIRUS STATE AND LOCAL FISCAL RECOVERY FUNDS |
$194,284 |
| 16.575 |
CRIME VICTIM ASSISTANCE |
$159,191 |
| 97.036 |
DISASTER GRANTS - PUBLIC ASSISTANCE (PRESIDENTIALLY DECLARED DISASTERS) |
$134,535 |
| 93.788 |
OPIOID STR |
$115,998 |
| 93.173 |
RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS |
$115,617 |
| 16.753 |
CONGRESSIONALLY RECOMMENDED AWARDS |
$66,902 |
| 93.RD |
A Phase II, Single-Stage, Single Arm Investigation of Oral Valganciclovir Therapy in Infants with Asymptomatic Congenital Cytomegalovirus Infection |
$37,305 |
| 93.RD |
AWD00002326 NCI A022104 CLT |
$34,031 |
| 93.145 |
HIV-RELATED TRAINING AND TECHNICAL ASSISTANCE |
$30,925 |
| 93.078 |
STRENGTHENING EMERGENCY CARE DELIVERY IN THE UNITED STATES HEALTHCARE SYSTEM THROUGH HEALTH INFORMATION AND PROMOTION |
$28,732 |
| 93.847 |
DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH |
$21,872 |
| 93.RD |
Impact of the COVID-19 pandemic, SARS-CoV-2 |
$17,941 |
| 93.RD |
AWD00002145 Kaplan CMHA ASCT2031 |
$16,598 |
| 93.RD |
S2308_CLT_AWD00002717 |
$13,503 |
| 93.837 |
CARDIOVASCULAR DISEASES RESEARCH |
$12,344 |
| 93.399 |
CANCER CONTROL |
$11,904 |
| 93.RD |
SWOG |
$11,856 |
| 93.958 |
BLOCK GRANTS FOR COMMUNITY MENTAL HEALTH SERVICES |
$11,563 |
| 93.RD |
ALLIANCE for Clinical Trials in Oncology |
$11,436 |
| 14.251 |
ECONOMIC DEVELOPMENT INITIATIVE, COMMUNITY PROJECT FUNDING, AND MISCELLANEOUS GRANTS |
$8,595 |
| 93.RD |
NMDP Adults Registry |
$7,969 |
| 93.RD |
CIBMTR Registry |
$7,783 |
| 93.RD |
NMTRC 014 |
$7,704 |
| 93.RD |
Bhutani_SWOG_S2005_CLT_AWD00002919 |
$6,560 |
| 93.853 |
EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS |
$5,967 |
| 93.RD |
Rider TransIT |
$5,404 |
| 12.420 |
MILITARY MEDICAL RESEARCH AND DEVELOPMENT |
$5,196 |
| 93.RD |
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors |
$4,862 |
| 93.RD |
NMTRC012 |
$4,744 |
| 93.073 |
BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES - PREVENTION AND SURVEILLANCE |
$4,010 |
| 93.RD |
AREN1921 |
$3,836 |
| 93.RD |
A Randomized Phase III Trial of Consolidation with Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs. Maintenance Rituximab Alone for Patients with Mantle Cell Lymphoma In Minimal Residual Disease-Negative First |
$3,332 |
| 93.RD |
A222004 |
$3,266 |
| 93.RD |
AWD00002605 Kaplan NCI COG ANBL2131 |
$2,827 |
| 93.395 |
CANCER TREATMENT RESEARCH |
$2,783 |
| 93.855 |
ALLERGY AND INFECTIOUS DISEASES RESEARCH |
$2,566 |
| 93.110 |
SPECIAL PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE |
$2,389 |
| 93.866 |
AGING RESEARCH |
$1,911 |
| 12.300 |
BASIC AND APPLIED SCIENTIFIC RESEARCH |
$1,716 |
| 93.RD |
Sickle Cell #1507 |
$1,035 |
| 93.262 |
OCCUPATIONAL SAFETY AND HEALTH PROGRAM |
$849 |
| 93.394 |
CANCER DETECTION AND DIAGNOSIS RESEARCH |
$783 |
| 93.RD |
National Experimental Therapeutics Consortium |
$724 |
| 93.RD |
ECOG-ACRIN - EA1141 |
$685 |
| 93.RD |
ANBL1531 |
$630 |
| 93.RD |
LCCC1317 |
$621 |
| 93.RD |
APEC1621_COG MATCH |
$547 |
| 93.RD |
MYELOMATCH_AWD00002888 |
$502 |
| 93.RD |
ARST2031 |
$500 |
| 93.RD |
ACNS1931 |
$434 |
| 93.RD |
Knight_Thomas_NCI_MM1YA-CTG01-CLT |
$417 |
| 93.137 |
COMMUNITY PROGRAMS TO IMPROVE MINORITY HEALTH |
$380 |
| 93.667 |
SOCIAL SERVICES BLOCK GRANT |
$228 |
| 93.RD |
ALTE1631 |
$210 |
| 93.RD |
C11173_BMT CTN2207_CLT |
$206 |
| 93.RD |
AHOD1331 |
$144 |
| 93.RD |
AGCT1532 |
$129 |
| 93.RD |
ARST2032 |
$129 |
| 93.RD |
A021806 |
$116 |
| 93.RD |
MMRC-089 |
$93 |
| 93.839 |
BLOOD DISEASES AND RESOURCES RESEARCH |
$43 |
| 93.360 |
BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA), BIODEFENSE MEDICAL COUNTERMEASURE DEVELOPMENT |
$-4,155 |
| 93.310 |
TRANS-NIH RESEARCH SUPPORT |
$-13,543 |
| 93.865 |
CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH |
$-53,508 |